Financial Support
Assistance with connecting patients to relevant saving options
At Novartis Patient Support, we understand that affordability is important.
That’s why we offer a range of savings options and resources to help your eligible patients access treatment regardless of their ability to pay.
Once we’ve determined your patient’s coverage status, we’ll help connect them to any appropriate financial support offering.
Co-Pay Plus offer
With one sign-up, Co-Pay Plus can help your eligible patients with private insurance:
Get FABHALTA if coverage is delayed. Co-Pay Plus can provide up to 12 months of FABHALTA for free while seeking coverage
Pay for FABHALTA out-of-pocket costs once coverage is approved, including Vaccination costs. Out-of-pocket costs could be your patient’s co-pay, co-insurance, or deductible
To sign up:
Limitations apply. Patients with private insurance coverage for FABHALTA may receive up to $20,000 in annual co-pay benefits for the cost of FABHALTA and up to $1,000 for qualifying vaccination costs (excluding administrative fees). Patient is responsible for any costs once the limit is reached in a calendar year. Program not valid (i) under Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program, (ii) where patient is not using insurance coverage at all, (iii) where the patient’s insurance plan reimburses for the entire cost of the drug, or (iv) where product is not covered by patient’s insurance. The value of this Program is exclusively for the benefit of patients and is intended to be credited towards patient out-of-pocket obligations and maximums, including applicable co-payments, coinsurance, and deductibles. Patient may not seek reimbursement for the value received from this Program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account. Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use of the Program. Valid only in the United States, Puerto Rico, and select territories. Void where prohibited by law. Additional restrictions may apply. This Program is not health insurance. Program may not be combined with any third-party rebate, coupon, or offer. Proof of purchase may be required. Novartis reserves the right to rescind, revoke, or amend this Program and discontinue support at any time without notice.
Co-Pay Plus offer
The Bridge Program
Once patients enroll in Novartis Patient Support, we automatically identify if they are eligible* for the Bridge Program based on the results of the benefits verification.
*To be eligible for the Bridge Program, patients must have: private insurance and a valid prescription for FABHALTA.
The Bridge Program applies to FABHALTA only. Eligible patients must have private insurance and a valid prescription for FABHALTA, and a prior authorization or an initial denial of coverage. Program requires the submission of a prior authorization or an appeal of the coverage denial within the first 45 days of enrollment to remain eligible. Program provides FABHALTA for free to eligible patients for up to 12 months, or until they receive insurance coverage approval, whichever occurs earlier. A valid prescription consistent with FDA-approved labeling is required. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, TRICARE, or any other federal or state program. Patients may be asked to reverify insurance coverage status during the course of the Program. No purchase necessary. Program is not health insurance, nor is participation a guarantee of insurance coverage. Additional limitations may apply. Novartis Pharmaceuticals Corporation reserves the right to rescind, revoke, or amend this Program without notice.